C-Met expression is associated with time to recurrence in patients with glioblastoma multiforme

Journal of Clinical Neuroscience

Volumn 18, Issue 1, 2011, Pages 119-121

  Liu, Wei ^a   Fu, Yibing ^a   Xu, Shangchen ^a   Ding, Feng ^a   Zhao, Guangyu ^a   Zhang, Kang ^a   Du, Chigang ^a   Pang, Bo ^b   Pang, Qi ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

C Met; Glioblastoma; Progression free survival time; Recurrence

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SURVIVAL TIME;

ADULT; AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 78650179903     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.05.010     Document Type: Article

References (25)

1. P. Yuile, O. Dent, and R. Cook Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables J Clin Neurosci 13 2006 747 751 (Pubitemid 44354178)
2. A.A. Brandes, A. Tosoni, and E. Franceschi Glioblastoma in adults Crit Rev Oncol Hematol 67 2008 139 152
3. M.L. Wong, A.H. Kaye, and C.M. Hovens Targeting malignant glioma survival signalling to improve clinical outcomes J Clin Neurosci 14 2007 301 308 (Pubitemid 46335778)
4. D. Brandsma, and M.J. van den Bent Molecular targeted therapies and chemotherapy in malignant gliomas Curr Opin Oncol 19 2007 598 605
5. D.N. Louis Molecular pathology of malignant gliomas Annu Rev Pathol 1 2006 97 117
6. Y. Liu The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization Gene 215 1998 159 169 (Pubitemid 28359229)
7. C. Birchmeier, W. Birchmeier, and E. Gherardi Met, metastasis, motility and more Nat Rev Mol Cell Biol 4 2003 915 925 (Pubitemid 37493640)
8. W.K. You, and D.M. McDonald The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis BMB Rep 41 2008 833 839
9. S. Benvenuti, and P.M. Comoglio The MET receptor tyrosine kinase in invasion and metastasis J Cell Physiol 213 2007 316 325 (Pubitemid 47509708)
10. Y.W. Zhang, and G.F. Vande Woude HGF/SF-met signaling in the control of branching morphogenesis and invasion J Cell Biochem 88 2003 408 417 (Pubitemid 36119916)
11. H.Y. Zhou, K.F. Wan, and C.K. Ip Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK FEBS Lett 582 2008 3415 3422
12. A.W. Ke, G.M. Shi, and J. Zhou Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma Hepatology 49 2009 491 503
13. C.T. Lee, N.H. Chow, and P.F. Su The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer Dis Colon Rectum 51 2008 1268 1274
14. R. Ramirez, D. Hsu, and A. Patel Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma Clin Endocrinol (Oxf) 53 2000 635 644
15. E. Comperat, M. Roupret, and E. Chartier-Kastler Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract J Urol 179 2008 868 872 [discussion 72]
16. Y. Li, B. Lal, and S. Kwon The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy Cancer Res 65 2005 9355 9362 (Pubitemid 41508003)
17. T. Naka, D. Kuester, and C. Boltze Expression of hepatocyte growth factor and c-MET in skull base chordoma Cancer 112 2008 104 110
18. C.H. Kim, S.K. Moon, and J.H. Bae Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma Acta Otolaryngol 126 2006 88 94
19. K. Kajiya, S. Hirakawa, and B. Ma Hepatocyte growth factor promotes lymphatic vessel formation and function EMBO J 24 2005 2885 2895 (Pubitemid 43079892)
20. S. Ding, T. Merkulova-Rainon, and Z.C. Han HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro Blood 101 2003 4816 4822 (Pubitemid 36857740)
21. R. Abounader, and J. Laterra Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis Neuro Oncol 7 2005 436 451 (Pubitemid 41555616)
22. Z.S. Zeng, M.R. Weiser, and E. Kuntz c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases Cancer Lett 265 2008 258 269
23. K. Nabeshima, Y. Shimao, and S. Sato Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study Histopathology 31 1997 436 443 (Pubitemid 27505360)
24. S. Chu, X. Yuan, and Z. Li c-Met antisense oligodeoxynucleotide inhibits growth of glioma cells Surg Neurol 65 2006 533 538 [discussion 8] (Pubitemid 43729600)
25. D.S. Kong, S.Y. Song, and D.H. Kim Prognostic significance of c-Met expression in glioblastomas Cancer 115 2009 140 148